Replies to post #11147 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Good list and yes the company is trying to take advantage of the Covid-mania and has done well by raising capital and making key acquisitions for the future 2 - 5 years out.
As far as the 25 million Covi-Stix, Mexico has put a upper limit on what can be imported and we do not know what the delivery schedule is or where they would ultimately go; you need buyers. The way Sorrento has operated we may not know anything until the 3rd Q.
SP 102 is my best hope for H1 2022 and then there are the EUA's.
A little slow on the uptake but so are mile long freight trains, so once it starts to roll (SP 102) she will be hard to stop.

[purefreewater]

Sorrento received $34,000,000 USD from the government in November of last year!

Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic, Gene-Encoded Protective Antibody Platform Against Coronavirus” (HR0011-21-9-0015) to support the development of an STI-2020-encoded Gene MAbTM through Phase 2 clinical studies.

STI-2020-encoded Gene MAb is in development for intramuscular injection against the SARS-CoV-2 virus and its variant strains to produce potent STI-2020 nAbs in the body.

STI-2020-encoded Gene MAb products can potentially be stored at refrigerator temperatures, avoiding some of the cold chain management challenges associated with the deployment of COVID-19 vaccines currently in development.

Sorrento has a cGMP facility in place to meet initial production demand and Sorrento expects that STI-2020-encoded Gene MAb can be produced in large quantity to meet potentially high demand.
______________________________________________________________

Then there was the successful infusion of 10 people
in the initial trials that shot up our PPS to $19
and the results of following trials are about to be announced soon .

I would focus on these 2 HUGE success stories right now.

What do you ALL think ?



TIA ............ go Sorrento !